| 000 | 01396nam a2200385 i 4500 | ||
|---|---|---|---|
| 001 | on1001313463 | ||
| 003 | OCoLC | ||
| 005 | 20170911112253.0 | ||
| 006 | m o d f | ||
| 007 | cr mn||||||||| | ||
| 008 | 170817s2016 dcua o f000 0 eng c | ||
| 040 |
_aGPO _beng _erda _epn _cGPO _dMvI |
||
| 042 | _apcc | ||
| 074 | _a0967 (online) | ||
| 086 | 0 | _aJ 24.2:P 92/4 | |
| 099 | _aJ 24.2:P 92/4 | ||
| 245 | 0 | 0 |
_aCounterfeit prescription pills containing fentanyls : _ba global threat / _cprepared by the DEA Strategic Intelligence Section. |
| 264 | 1 |
_a[Washington, D.C.] : _bDEA Strategic Intelligence Section, _c2016. |
|
| 300 |
_a1 online resource (9 pages) : _bcolor illustrations. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 490 | 0 | _aDEA intelligence brief | |
| 500 | _a"Unclassified." | ||
| 500 | _a"DEA-DCT-DIB-021-16." | ||
| 500 | _a"July 2016." | ||
| 500 | _aCRDP Program record. | ||
| 588 | _aDescription based on online resource, PDF version; title from title page (DEA, viewed Aug. 17, 2017). | ||
| 650 | 0 | _aFentanyl. | |
| 650 | 0 | _aOpioid abuse. | |
| 650 | 0 | _aDrug adulteration. | |
| 650 | 0 | _aProduct counterfeiting. | |
| 650 | 0 | _aDrug traffic. | |
| 710 | 1 |
_aUnited States. _bDrug Enforcement Administration. _bStrategic Intelligence Section, _eissuing body. |
|
| 856 | 4 | 0 | _uhttps://purl.fdlp.gov/GPO/gpo83876 |
| 999 |
_c266683 _d266683 |
||